Literature DB >> 24290115

Protective role of resting heart rate on all-cause and cardiovascular disease mortality.

Arpit Saxena1, Dawn Minton, Duck-chul Lee, Xuemei Sui, Raja Fayad, Carl J Lavie, Steven N Blair.   

Abstract

OBJECTIVE: To study the protective role of lower resting heart rate (RHR) in cardiovascular disease (CVD) and all-cause mortality. PATIENTS AND METHODS: Patients (n=53,322) who received a baseline medical examination between January 1, 1974, and December 31, 2002, were recruited from the Cooper Clinic, Dallas, Texas. They completed a medical questionnaire and underwent clinical evaluation. Patients with CVD or cancer or who had less than 1 year of mortality follow-up were excluded from the study. Relative risks and 95% CIs for all-cause and CVD mortality across RHR categories were estimated using Cox proportional hazards models.
RESULTS: Highest cardiorespiratory fitness with lower mortality was found in individuals with an RHR of less than 60 beats/min. Similarly, patients with a higher RHR (≥80 beats/min) were at greater risk for CVD and all-cause mortality compared with an RHR of less than 60 beats/min. This analysis was followed by stratification of the data by hypertension, where hypertensive individuals with high RHRs (≥80 beats/min) were found to be at greater risk for CVD and all-cause mortality compared with those with hypertension and lower RHRs (<60 beats/min). In addition, unfit individuals with high RHRs had the greatest risk of CVD and all-cause mortality. The unfit with low RHR group had a similar risk for CVD and all-cause mortality as the fit with high RHR group.
CONCLUSION: Lower cardiorespiratory fitness levels and higher RHRs are linked to greater CVD and all-cause mortality.
Copyright © 2013 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ACLS; Aerobics Center Longitudinal Study; BP; CHD; CRF; CV; CVD; HR; HTN; PA; RHR; blood pressure; cardiorespiratory fitness; cardiovascular; cardiovascular disease; coronary heart disease; hazard ratio; hypertension; physical activity; resting heart rate

Mesh:

Year:  2013        PMID: 24290115      PMCID: PMC3908776          DOI: 10.1016/j.mayocp.2013.09.011

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  43 in total

1.  Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity).

Authors:  Paul D Thompson; David Buchner; Ileana L Pina; Gary J Balady; Mark A Williams; Bess H Marcus; Kathy Berra; Steven N Blair; Fernando Costa; Barry Franklin; Gerald F Fletcher; Neil F Gordon; Russell R Pate; Beatriz L Rodriguez; Antronette K Yancey; Nanette K Wenger
Journal:  Circulation       Date:  2003-06-24       Impact factor: 29.690

Review 2.  Physical activity for health: What kind? How much? How intense? On top of what?

Authors:  Kenneth E Powell; Amanda E Paluch; Steven N Blair
Journal:  Annu Rev Public Health       Date:  2011       Impact factor: 21.981

3.  The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study)

Authors:  E Kristal-Boneh; H Silber; G Harari; P Froom
Journal:  Eur Heart J       Date:  2000-01       Impact factor: 29.983

4.  Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure.

Authors:  A Benetos; A Rudnichi; F Thomas; M Safar; L Guize
Journal:  Hypertension       Date:  1999-01       Impact factor: 10.190

5.  Cardiorespiratory fitness as a predictor of nonfatal cardiovascular events in asymptomatic women and men.

Authors:  Xuemei Sui; Michael J LaMonte; Steven N Blair
Journal:  Am J Epidemiol       Date:  2007-04-03       Impact factor: 4.897

6.  Cardiorespiratory fitness and metabolic risk.

Authors:  Scott M Grundy; Carolyn E Barlow; Stephen W Farrell; Gloria L Vega; William L Haskell
Journal:  Am J Cardiol       Date:  2012-01-03       Impact factor: 2.778

Review 7.  Mortality trends in the general population: the importance of cardiorespiratory fitness.

Authors:  Duck-chul Lee; Enrique G Artero; Xuemei Sui; Steven N Blair
Journal:  J Psychopharmacol       Date:  2010-11       Impact factor: 4.153

8.  Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations.

Authors:  P Palatini; E Casiglia; P Pauletto; J Staessen; N Kaciroti; S Julius
Journal:  Hypertension       Date:  1997-11       Impact factor: 10.190

9.  Blood pressure and hypertension in middle-aged British men.

Authors:  A G Shaper; D Ashby; S J Pocock
Journal:  J Hypertens       Date:  1988-05       Impact factor: 4.844

10.  Associations of cardiorespiratory fitness and obesity with risks of impaired fasting glucose and type 2 diabetes in men.

Authors:  Duck-Chul Lee; Xuemei Sui; Timothy S Church; I-Min Lee; Steven N Blair
Journal:  Diabetes Care       Date:  2008-11-04       Impact factor: 17.152

View more
  26 in total

1.  Association between resting heart rate and cardiovascular mortality: evidence from a meta-analysis of prospective studies.

Authors:  Yuechun Li
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Resting heart rate and all-cause and cardiovascular mortality in the general population: a meta-analysis.

Authors:  Dongfeng Zhang; Xiaoli Shen; Xin Qi
Journal:  CMAJ       Date:  2015-11-23       Impact factor: 8.262

3.  Effect of heart rate on hospital mortality in critically ill patients may be modified by age: a retrospective observational study from large database.

Authors:  Dawei Zhou; Zhimin Li; Guangzhi Shi; Jianxin Zhou
Journal:  Aging Clin Exp Res       Date:  2020-07-07       Impact factor: 3.636

4.  Effects of exercise training intensity on cardiac autonomic regulation in habitual smokers.

Authors:  Choun-Sub Kim; Maeng-Kyu Kim; Hye-Young Jung; Mi-Ji Kim
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-03-01       Impact factor: 1.468

5.  Recent publications by ochsner authors: october 2013 - march 2014.

Authors: 
Journal:  Ochsner J       Date:  2014

6.  High responders and low responders: factors associated with individual variation in response to standardized training.

Authors:  Theresa N Mann; Robert P Lamberts; Michael I Lambert
Journal:  Sports Med       Date:  2014-08       Impact factor: 11.136

7.  Resting heart rate in first year survivors of myocardial infarction and long-term mortality: a community study.

Authors:  Patricia Jabre; Véronique L Roger; Susan A Weston; Frédéric Adnet; Ruoxiang Jiang; Benoit Vivien; Jean-Philippe Empana; Xavier Jouven
Journal:  Mayo Clin Proc       Date:  2014-10-31       Impact factor: 7.616

8.  Effect of a Long-Term Physical Activity Intervention on Resting Pulse Rate in Older Persons: Results from the Lifestyle Interventions and Independence for Elders Study.

Authors:  Bríain Ó Hartaigh; Laura C Lovato; Marco Pahor; Thomas W Buford; John A Dodson; Daniel E Forman; Matthew P Buman; Jamehl L Demons; Adam J Santanasto; Christine Liu; Michael E Miller; Mary McGrae McDermott; Thomas M Gill
Journal:  J Am Geriatr Soc       Date:  2016-10-27       Impact factor: 5.562

9.  Major depressive disorder with melancholia displays robust alterations in resting state heart rate and its variability: implications for future morbidity and mortality.

Authors:  Andrew H Kemp; Daniel S Quintana; Candice R Quinn; Patrick Hopkinson; Anthony W F Harris
Journal:  Front Psychol       Date:  2014-11-27

10.  A genome-wide interaction analysis of tricyclic/tetracyclic antidepressants and RR and QT intervals: a pharmacogenomics study from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.

Authors:  Raymond Noordam; Colleen M Sitlani; Christy L Avery; James D Stewart; Stephanie M Gogarten; Kerri L Wiggins; Stella Trompet; Helen R Warren; Fangui Sun; Daniel S Evans; Xiaohui Li; Jin Li; Albert V Smith; Joshua C Bis; Jennifer A Brody; Evan L Busch; Mark J Caulfield; Yii-Der I Chen; Steven R Cummings; L Adrienne Cupples; Qing Duan; Oscar H Franco; Rául Méndez-Giráldez; Tamara B Harris; Susan R Heckbert; Diana van Heemst; Albert Hofman; James S Floyd; Jan A Kors; Lenore J Launer; Yun Li; Ruifang Li-Gao; Leslie A Lange; Henry J Lin; Renée de Mutsert; Melanie D Napier; Christopher Newton-Cheh; Neil Poulter; Alexander P Reiner; Kenneth M Rice; Jeffrey Roach; Carlos J Rodriguez; Frits R Rosendaal; Naveed Sattar; Peter Sever; Amanda A Seyerle; P Eline Slagboom; Elsayed Z Soliman; Nona Sotoodehnia; David J Stott; Til Stürmer; Kent D Taylor; Timothy A Thornton; André G Uitterlinden; Kirk C Wilhelmsen; James G Wilson; Vilmundur Gudnason; J Wouter Jukema; Cathy C Laurie; Yongmei Liu; Dennis O Mook-Kanamori; Patricia B Munroe; Jerome I Rotter; Ramachandran S Vasan; Bruce M Psaty; Bruno H Stricker; Eric A Whitsel
Journal:  J Med Genet       Date:  2016-12-30       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.